ULK1 and esophageal adenocarcinoma: The reversal of EMT phenotypes by RAPA and DAPT further confirms that the effects of SNHG1 are mediated via the ULK1-Notch1 axis, highlighting its potential as a therapeutic target in Barrett’s esophagus.